Markets:

Overview

News

Currencies

International

Treasuries

Avadel Pharmaceuticals plc - Ordinary Share (NQ:AVDL)

21.34 -0.01 (-0.05%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avadel Pharmaceuticals plc - Ordinary Share

< Previous 1 2 3 4 5 6 Next >

Halper Sadeh LLC Encourages GIFI, AVDL, JAMF, CDE Shareholders to Contact the Firm to Discuss Their Rights

December 04, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge ↗

November 19, 2025

Via Stocktwits

Halper Sadeh LLC Encourages HFWA, FITB, AVDL, BRNS Shareholders to Contact the Firm to Discuss Their Rights

November 18, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Top 2 Health Care Stocks That May Fall Off A Cliff This Month ↗

November 17, 2025

Via Benzinga

Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal ↗

November 14, 2025

Avadel reviews Lundbeck's unsolicited $23 offer while maintaining its agreement with Alkermes as its board evaluates whether the new proposal could be superior.

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 14, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.

Via Chartmill

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗

November 14, 2025

Via Benzinga

Avadel Surges 20% On Lundbeck's Surprise Alkermes-Topping Bid ↗

November 14, 2025

A new bidding war could kick off in biotech with Avadel Pharmaceuticals at the center.

Via Investor's Business Daily

Halper Sadeh LLC Encourages TRUE, AVDL, GES Shareholders to Contact the Firm to Discuss Their Rights

November 14, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 14, 2025

Via Benzinga

Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes ↗

November 14, 2025

Avadel’s board of directors is of the opinion that the fresh proposal would reasonably be expected to be considered superior to the company’s existing agreement with Alkermes.

Via Stocktwits

Avadel Pharmaceuticals (NASDAQ:AVDL) Meets Minervini Trend Template with High-Growth Momentum ↗

November 06, 2025

Avadel Pharmaceuticals (AVDL) meets the Mark Minervini Trend Template with a strong technical uptrend and accelerating earnings and sales growth momentum.

Via Chartmill

Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups ↗

October 24, 2025

Four Roses, Six Flags, and Trump's potential Quantum investments: This week's deal activity involves big bets across various sectors.

Via Benzinga

Topics Government

HALPER SADEH LLC ENCOURAGES FSFG, AVDL, MBCN SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

October 23, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

Tesla To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Thursday ↗

October 23, 2025

Via Benzinga

This Winnebago Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

October 23, 2025

Via Benzinga

Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL

October 22, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz ↗

October 22, 2025

Alkermes agrees to acquire Avadel for $2.1 billion, adding the successful Lumryz drug and accelerating entry into sleep medicine. Jazz litigation settled.

Via Benzinga

Beyond The Numbers: 5 Analysts Discuss Avadel Pharmaceuticals Stock ↗

October 22, 2025

Via Benzinga

Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition

October 22, 2025

DUBLIN, IRELAND – October 22, 2025 – Avadel Pharmaceuticals (NASDAQ: AVDL) shareholders are celebrating today as Alkermes plc (NASDAQ: ALKS) announced a definitive agreement to acquire the company for...

Via MarketMinute

Topics Intellectual Property

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated

October 22, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives. ↗

October 22, 2025

The companies are both working in the sleep space, focusing on excessive daytime sleepiness.

Via Investor's Business Daily

Avadel Stock Rises After Acquisition Offer By Alkermes ↗

October 22, 2025

Alkermes will buy Avadel for up to $20 per share.

Via Stocktwits

AVDL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avadel Pharmaceuticals plc Is Fair to Shareholders

October 22, 2025

From Halper Sadeh LLC

Via Business Wire

What 4 Analyst Ratings Have To Say About Avadel Pharmaceuticals ↗

September 03, 2025

Via Benzinga

This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

September 03, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 21, 2025

Via Benzinga

Avadel (AVDL) Q2 Revenue Jumps 64% ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

Avadel Pharmaceuticals (NASDAQ:AVDL) Surges 6.3% in Pre-Market as Q2 Earnings Crush Estimates on Strong LUMRYZ Performance ↗

August 07, 2025

Avadel Pharmaceuticals (AVDL) beats Q2 2025 estimates with $68.1M revenue and $0.10 EPS, driven by strong LUMRYZ™ adoption. Stock surges 6.3% pre-market.

Via Chartmill

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.